Nurix Therapeutics Inc (NRIX)
22.05
-0.32
(-1.43%)
USD |
NASDAQ |
Nov 22, 16:00
21.50
-0.55
(-2.49%)
After-Hours: 20:00
Nurix Therapeutics Shareholders Equity (Quarterly): 376.86M for Aug. 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | 376.86M |
| May 31, 2024 | 370.69M |
| February 29, 2024 | 168.75M |
| November 30, 2023 | 200.49M |
| August 31, 2023 | 233.82M |
| May 31, 2023 | 259.92M |
| February 28, 2023 | 274.05M |
| November 30, 2022 | 303.70M |
| August 31, 2022 | 342.54M |
| May 31, 2022 | 266.74M |
| Date | Value |
|---|---|
| February 28, 2022 | 305.92M |
| November 30, 2021 | 342.30M |
| August 31, 2021 | 375.22M |
| May 31, 2021 | 398.18M |
| February 28, 2021 | 270.13M |
| November 30, 2020 | 290.27M |
| August 31, 2020 | 307.62M |
| May 31, 2020 | 106.58M |
| November 30, 2019 | -57.71M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-57.71M
Minimum
Nov 2019
398.18M
Maximum
May 2021
270.32M
Average
290.27M
Median
Nov 2020
Shareholders Equity (Quarterly) Benchmarks
| Enzo Biochem Inc | 56.11M |
| Neogen Corp | 3.135B |
| Pfizer Inc | 92.29B |
| Zymeworks Inc | 366.98M |
| Accolade Inc | 423.07M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 513.60M |
| Total Liabilities (Quarterly) | 136.74M |
| Current Ratio | 5.285 |